CoLucid Pharmaceuticals Inc (CLCD) - Financial and Strategic SWOT Analysis Review

  • ID: 4284799
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4

CoLucid Pharmaceuticals Inc (CoLucid) is a pharmaceutical company that conducts research and develops new therapies. CoLucid’s lead product candidate Lasmiditan (COL-144), is an oral tablet that penetrates the central nervous system and selectively targets 5-HT1F receptors expressed in the trigeminal nerve pathway. It’s been designed to deliver efficacy for the acute treatment of migraine in adults without the vasoconstrictor activity and clinical limitations associated with previous generations of migraine therapies. The company offers oral lasmiditan for the treatment of migraine headaches; and intravenous lasmiditan to treat unspecified headache pain in adults. CoLucid is headquartered in Cambridge, Massachusetts, the US.

CoLucid Pharmaceuticals Inc Key Recent Developments

Nov 09, 2016: CoLucid Pharmaceuticals Announces 2016 Third Quarter Results and Corporate Highlights
Aug 10, 2016: CoLucid Pharmaceuticals Announces 2016 Second Quarter Results and Corporate Highlights
May 11, 2016: CoLucid Pharmaceuticals Announces 2016 First Quarter Results and Corporate Highlights
Mar 02, 2016: CoLucid Pharmaceuticals Announces 2015 Fourth Quarter and Year-End Results and Corporate Highlights

This comprehensive SWOT profile of CoLucid Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of CoLucid Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • CoLucid Pharmaceuticals Inc - Key Information
  • CoLucid Pharmaceuticals Inc - Overview
  • CoLucid Pharmaceuticals Inc - Key Employees
  • CoLucid Pharmaceuticals Inc - Key Employee Biographies
  • CoLucid Pharmaceuticals Inc - Key Operational Heads
  • CoLucid Pharmaceuticals Inc - Major Products and Services
  • CoLucid Pharmaceuticals Inc - History
  • CoLucid Pharmaceuticals Inc - Company Statement
  • CoLucid Pharmaceuticals Inc - Locations And Subsidiaries
  • CoLucid Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • CoLucid Pharmaceuticals Inc - Business Description
  • CoLucid Pharmaceuticals Inc - Corporate Strategy
  • CoLucid Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • CoLucid Pharmaceuticals Inc - Strengths
  • CoLucid Pharmaceuticals Inc - Weaknesses
  • CoLucid Pharmaceuticals Inc - Opportunities
  • CoLucid Pharmaceuticals Inc - Threats
  • CoLucid Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • CoLucid Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • CoLucid Pharmaceuticals Inc, Key Information
  • CoLucid Pharmaceuticals Inc, Key Ratios
  • CoLucid Pharmaceuticals Inc, Share Data
  • CoLucid Pharmaceuticals Inc, Major Products and Services
  • CoLucid Pharmaceuticals Inc, History
  • CoLucid Pharmaceuticals Inc, Key Employees
  • CoLucid Pharmaceuticals Inc, Key Employee Biographies
  • CoLucid Pharmaceuticals Inc, Key Operational Heads
  • CoLucid Pharmaceuticals Inc, Other Locations
  • CoLucid Pharmaceuticals Inc, Subsidiaries
  • CoLucid Pharmaceuticals Inc, Key Manufacturing facilities
  • CoLucid Pharmaceuticals Inc, Key Competitors
  • CoLucid Pharmaceuticals Inc, SWOT Analysis
  • CoLucid Pharmaceuticals Inc, Ratios based on current share price
  • CoLucid Pharmaceuticals Inc, Annual Ratios
  • CoLucid Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • CoLucid Pharmaceuticals Inc, Performance Chart
  • CoLucid Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown